Evidence map›Paper›PMID 22434868›Full record

ArticleDevelopment (Cambridge, England)2012

The transcriptional co-repressor Grg3/Tle3 promotes pancreatic endocrine progenitor delamination and β-cell differentiation.

David E Metzger, Malgorzata Gasperowicz, Florian Otto, James C Cross, Gerard Gradwohl, Kenneth S Zaret

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Transcriptional control of mammalian pancreas organogenesis.Cellular and molecular life sciences : CMLS · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David E MetzgerInstitute for Regenerative Medicine, Institute for Diabetes Obesity and Metabolism, Epigenetics Program, Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine,1056 BRB II/III, 421 Curie Boulevard, Philadelphia, PA 19104, USA. dmetzger@upenn.edu
Malgorzata Gasperowicz
Florian Otto
James C Cross
Gerard Gradwohl
Kenneth S Zaret
University of Calgary · CA

Funding

TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
Diabetes, Endocrine, and MetabolismT32DK007314 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DORIS A STOFFERS, Patrick Seale · 1986 to 2026
$9.0M
Gene Regulatory Signals for Beta Cell DevelopmentU01DK072503 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI ZARET, KENNETH · 2005 to 2009
$3.5M
NCI NIH HHS T32 CA009035NCI NIH HHS T32 CA-009035-32NIDDK NIH HHS T32 DK007314NIDDK NIH HHS U01 DK072503NIDDK NIH HHS UO1 DK072503
6 · The paper itself

Abstract

Pancreatic β-cells arise from Ngn3(+) endocrine progenitors within the trunk epithelium of the embryonic pancreas. The emergence of endocrine cells requires E-cadherin downregulation, but the crucial steps that elicit such are not clear, yet probably important for ultimately being able to efficiently generate β-cells de novo from stem cells. Grg3 (groucho-related gene 3, also known as Tle3), encodes a member of the Groucho/TLE family of co-repressors and its function in various cell contexts is mediated by recruitment to target genes by different transcription factors. Grg proteins broadly regulate the progression of progenitor cells to differentiated cell types, but specific developmental mechanisms have not been clear. We find that Grg3 is expressed in most β-cells and a subset of other endocrine cell types in the pancreas. Grg3 is highly expressed in Ngn3(+) endocrine progenitor descendants just after transient Ngn3 expression. Grg3-null embryos die at E14.5, which is associated with placental defects, so we explanted E12.5 pancreata to allow endocrine differentiation to occur in culture. Grg3 knockout explants displayed a drastic decrease in the differentiation of all endocrine cell types owing to defects in the delamination of early endocrine progenitors from the trunk epithelium. We find that Grg3 normally suppresses E-cadherin gene expression, thereby allowing delamination of endocrine cells from the trunk epithelium and revealing how this transcriptional co-repressor modulates this crucial step of β-cell development.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsApoptosisBasic Helix-Loop-Helix ProteinsCadherinsCell DifferentiationCell ProliferationCo-Repressor ProteinsInsulin-Secreting CellsIslets of LangerhansMiceMice, KnockoutModels, BiologicalNerve Tissue ProteinsPancreasProteinsBasic Helix-Loop-Helix ProteinsCadherinsCo-Repressor ProteinsNerve Tissue ProteinsNeurog3 protein, mouseProteinsTle3 protein, mouse

Identifiers

PMID22434868
PMCPMC3308179
OpenAlexW2046607076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.